Home > Riviste > Minerva Cardioangiologica > Fascicoli precedenti > Articles online first > Minerva Cardioangiologica 2020 Feb 26

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

 

Minerva Cardioangiologica 2020 Feb 26

DOI: 10.23736/S0026-4725.20.05198-1

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Left main coronary artery disease: when and how to perform PCI?

Mauro CHIARITO 1, 2, Julinda MEHILLI 3, 4

1 Cardio Center, Humanitas Research Hospital, Rozzano, Milan, Italy; 2 Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; 3 Cardiology, University Hospital Munich, Ludwig-Maximilians University, Munich, Germany; 4 German Centre for Cardiovascular Research (DZHK), Munich Heart Alliance, Munich, Germany


PDF


Left main coronary artery (LMCA) disease has been reported in up to 10% of all patients with coronary artery disease (CAD) and in the majority of cases are associated with severe three-vessel CAD. Among patients with chronic coronary syndrome revascularization of significant LMCA disease improves prognosis, while there is a debate about which revascularization strategy, CABG surgery or percutaneous coronary interventions to use. We do a review of the available evidence about the impact of LMCA lesions on patient prognosis according to CAD extension and clinical presentation, the outcome after percutaneous or surgical revascularization, the procedural challenges of LMCA PCI and the available armamentarium to optimally treat this relevant population.


KEY WORDS: Left main coronary artery disease; Percutaneous coronary intervention; Drug eluting stent; Coronary artery bypass graft

inizio pagina